LINKS

AACE

American College of Cardiology

ASH-System Pharmacists

ClinicalTrials.gov

Clinical Laboratory Science Institute

CMS Quality Measures

Hospital Quality Alliance

Institute for Healthcare Improvement

Published Protocols

Society of Hospital Medicine

Surviving Sepsis Campaign

The Endocrine Society

Per Capita Health Care Spending on Diabetes:

2009-2013
www.healthcostinstitute.org

Diabetes is a costly chronic condition in the United States, medical costs and productivity loss attributable to diabetes were estimated to be $245 billion in 2012.1 In this issue brief, for individuals covered by employer-sponsored insurance (ESI) and younger than age 65, per capita spending for people with a diagnosis of diabetes was compared to those without a diagnosis for the years 2009 through 2013. During that period, spending for individuals with diabetes increased by roughly $1,000 to about $15,000 per capita. The average per capita spending difference between people with and without diabetes was $10,310 .

 

Additionally, during this period, people with diabetes spent on average 2.5 times more out of pocket than people without diabetes. Among individuals with diabetes, children (ages 0 through 18) and pre-Medicare adults (ages 55 through 64) were the two groups with the highest per capita health care spending in every year of the study period. More >

Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World
Systematic Review and Meta-analysis of Randomized Controlled Trials


Regional variation in type 2 diabetes mellitus care may affect outcomes in patients treated with intensive versus standard blood glucose control. We sought to evaluate these differences between North America and the rest of the world. More >

In-silico Closed Loop Control Validation Studies for Optimal Insulin Delivery in Type 1 Diabetes
Zavitsanou S, Mantalaris A, Georgiadis M, Pistikopoulos E.

This study presents a general closed loop control strategy for optimal insulin delivery in type 1 Diabetes Mellitus. The proposed control strategy aims towards an individualized optimal insulin delivery that consists of a patient-specific model predictive controller, a state estimator, a personalized scheduling level and an open loop optimization problem subjected to patient-specific process model and constraints. This control strategy can be also modified to address the case of limited patient data availability resulting in an "approximation" control strategy. More >

Glucose Meters in Critically Ill Patients:

What New Guidance Means for Labs
Clinical Laboratory News

What is all the buzz about use of glucose meters in critically ill patients? Glucose meters have been used for more than 30 years to provide rapid measurement of glucose on whole blood fingersticks from patients with diabetes. Originally developed for patient self-testing, glucose meter use has expanded throughout the healthcare industry. Meters currently are being used in physician offices, schools, nursing homes, ambulances, helicopters, airplanes, and cruise ships. Glucose meters have even traveled on the Space Shuttle! They are common throughout hospitals and are used for a variety of reasons, from quick checks of glucose levels to hourly glucose level monitoring as part of intensive insulin protocols. More >

Today's POCT
MAY 2015 ADVANCE/LABORATORY WWW.ADVANCEWEB.COM
By Jeffrey A. DuBois, PhD, HCLD/CC (ABB) FACB

Point-of-care test technologies must achieve agreement and concordance with central laboratory analyzer methods Point-of-care (POC) tests are now widely established in hospital settings, providing rapid results at the patient bedside. Increasingly, POC test methods are being used in pre-hospital settings and, as reported in the March 2015 edition1 of this magazine, are crossing the chasm into the primary care setting. More >

2015.  MDNLLC

 Back to top